It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
We report on single-molecule nanopore sensing combined with position-encoded DNA molecular probes, with chemistry tuned to simultaneously identify various antigen proteins and multiple RNA gene fragments of SARS-CoV-2 with high sensitivity and selectivity. We show that this sensing strategy can directly detect spike (S) and nucleocapsid (N) proteins in unprocessed human saliva. Moreover, our approach enables the identification of RNA fragments from patient samples using nasal/throat swabs, enabling the identification of critical mutations such as D614G, G446S, or Y144del among viral variants. In particular, it can detect and discriminate between SARS-CoV-2 lineages of wild-type B.1.1.7 (Alpha), B.1.617.2 (Delta), and B.1.1.539 (Omicron) within a single measurement without the need for nucleic acid sequencing. The sensing strategy of the molecular probes is easily adaptable to other viral targets and diseases and can be expanded depending on the application required.
Fast discrimination of SARS-CoV-2 variants in clinical samples remains a challenge. Here, authors report on single molecule nanopore sensing combined with DNA molecular probes to simultaneously detect various antigens and RNA mutations of SARS-CoV-2 variants in patient samples.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
















1 Molecular Sciences Research Hub, Department of Chemistry, Imperial College London, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111); Imperial College London, Department of Metabolism, Digestion and Reproduction, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111)
2 Molecular Sciences Research Hub, Department of Chemistry, Imperial College London, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111); University of Cambridge, Yusuf Hamied Department of Chemistry, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000 0001 2188 5934)
3 Chinese Academy of Sciences, The Key Laboratory of Zhejiang Province for Aptamers and Theranostics, Aptamer Selection Center, Hangzhou Institute of Medicine (HIM), Hangzhou, China (GRID:grid.9227.e) (ISNI:0000 0001 1957 3309)
4 Molecular Sciences Research Hub, Department of Chemistry, Imperial College London, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111)
5 The Francis Crick Institute, The Chromatin Structure and Mobile DNA Laboratory, London, UK (GRID:grid.451388.3) (ISNI:0000 0004 1795 1830); Imperial College London, Wolfson Education Centre, Faculty of Medicine, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111)
6 The Francis Crick Institute, The Chromatin Structure and Mobile DNA Laboratory, London, UK (GRID:grid.451388.3) (ISNI:0000 0004 1795 1830)
7 National University of Science and Technology “MISIS”, Moscow, Russian Federation (GRID:grid.35043.31) (ISNI:0000 0001 0010 3972)
8 ICAPPIC Limited, London, UK (GRID:grid.35043.31)
9 Imperial College London, Molecular Diagnostic Unit, Section of Virology, Department of Infectious Disease, Faculty of Medicine, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111)
10 Imperial College London, Section of Structural and Synthetic Biology, Department of Infectious Disease, Faculty of Medicine, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111)
11 Zhejiang University, State Key Laboratory of Modern Optical Instrumentation, College of Optical Science and Engineering, International Research Center for Advanced Photonics, Hangzhou, China (GRID:grid.13402.34) (ISNI:0000 0004 1759 700X)
12 Imperial College London, Department of Metabolism, Digestion and Reproduction, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111); ICAPPIC Limited, London, UK (GRID:grid.7445.2)
13 Imperial College London, Department of Metabolism, Digestion and Reproduction, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111)
14 The Francis Crick Institute, The Chromatin Structure and Mobile DNA Laboratory, London, UK (GRID:grid.451388.3) (ISNI:0000 0004 1795 1830); Imperial College London, Molecular Diagnostic Unit, Section of Virology, Department of Infectious Disease, Faculty of Medicine, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111)
15 Imperial College London, Department of Metabolism, Digestion and Reproduction, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111); Kanazawa University, Nano Life Science Institute (WPI-NanoLSI), Kanazawa, Japan (GRID:grid.9707.9) (ISNI:0000 0001 2308 3329)